Benjamin Freedman
Papers
1
Total Citations
461
H-Index
1
About
Benjamin Freedman is a leading figure in stem cell biology and kidney regeneration, best known for pioneering the development of kidney organoids from human pluripotent stem cells. His work has fundamentally advanced the field by enabling the creation of miniature, functional kidney tissues in the lab, which serve as powerful models for studying kidney development, disease, and drug toxicity. A standout contribution is his 2018 study, "High-Throughput Screening Enhances Kidney Organoid Differentiation from Human Pluripotent Stem Cells and Enables Automated Multidimensional Phenotyping," which has garnered over 460 citations. This work introduced high-throughput screening methods to optimize organoid differentiation and automated imaging for detailed phenotyping, dramatically improving the reproducibility and scalability of these models. Freedman’s research bridges fundamental biology and translational medicine, offering new avenues for personalized drug testing and potential cell-based therapies for kidney disease. His innovative use of automation and screening has set a new standard in the organoid field, making him a key influencer for students and researchers exploring regenerative medicine and 3D tissue engineering.
Research Focus
Key Achievements
Top Papers
- 1